Research Row: Impacting Downstream Capricor Therapeutics (Cap-1002) Edgewise Therapeutics (EDG-5506) FibroGen (Pamrevlumab) Antisense Therapeutics (ATL1102) Cumberland Pharmaceuticals (Ifetroban) 2023 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like Stronger Together: Empowering Families Through Community, Care, and Research – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings A New Era of Steroids, Endocrinology & Emergency Care – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings Opening Session: A New Era in Duchenne & Becker Muscular Dystrophy – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings The Impact of Diagnosis: Managing Family Dynamics – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings Exploring the Landscape of Gene Therapy – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings Trials & Treatments: Making Decisions that are Right for You – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings Building Friendships & Self Advocacy Skills – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings Keynote Address: Meeting the Challenge of Rare Disease – 2025 PPMD Annual Conference 18 hours ago 2025 PPMD Annual Conference,Conferences & Meetings 123…28»Page 1 of 28